Appian Way Asset Management LP Acquires 41,738 Shares of DarioHealth Corp. (NASDAQ:DRIO)

Appian Way Asset Management LP boosted its holdings in DarioHealth Corp. (NASDAQ:DRIO) by 3.1% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,375,880 shares of the company’s stock after acquiring an additional 41,738 shares during the quarter. Appian Way Asset Management LP owned 4.60% of DarioHealth worth $1,637,000 at the end of the most recent reporting period.

Separately, Clarity Capital Partners LLC lifted its holdings in shares of DarioHealth by 20.1% during the 1st quarter. Clarity Capital Partners LLC now owns 204,758 shares of the company’s stock worth $313,000 after acquiring an additional 34,332 shares during the last quarter. Institutional investors and hedge funds own 33.39% of the company’s stock.

DarioHealth Stock Down 7.0 %

DRIO opened at $0.93 on Tuesday. The business’s fifty day simple moving average is $0.96 and its 200 day simple moving average is $1.26. DarioHealth Corp. has a 52 week low of $0.68 and a 52 week high of $3.49. The company has a quick ratio of 1.96, a current ratio of 2.26 and a debt-to-equity ratio of 0.34. The stock has a market cap of $27.83 million, a PE ratio of -0.55 and a beta of 1.46.

DarioHealth (NASDAQ:DRIO) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.51) by $0.43. The firm had revenue of $6.26 million for the quarter, compared to analyst estimates of $7.57 million. DarioHealth had a negative return on equity of 74.64% and a negative net margin of 265.33%. As a group, research analysts expect that DarioHealth Corp. will post -1.21 earnings per share for the current fiscal year.

DarioHealth Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.